TPX2 antibody; C20orf1 antibody; C20orf2 antibody; DIL2 antibody; HCA519 antibody; Targeting protein for Xklp2 antibody; Differentially expressed in cancerous and non-cancerous lung cells 2 antibody; DIL-2 antibody; Hepatocellular carcinoma-associated antigen 519 antibody; Protein fls353 antibody; Restricted expression prolifera antibody;
Product description
developmental stage:Exclusively expressed in proliferating cells from the transition G1/S until the end of cytokinesis. PTM:Phosphorylated upon DNA damage, probably by ATM or ATR. subcellular location:During mitosis it is strictly associated with the spindle pole and with the mitotic spindle, whereas during S and G2, it is diffusely distributed throughout the nucleus. tissue specificity:Expressed in lung carcinoma cell lines but not in normal lung tissues.
Immunogen
The antiserum was produced against synthesized peptide derived from human DIL-2. AA range:301-350
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WBIHC
WB:1:500-1:2000 IHC:1:100-1:300
Species Reactivity
HumanMouse
Concentration
1mg/ml
Target Information
Alternative Names
TPX2 antibody C20orf1 antibody C20orf2 antibody DIL2 antibody HCA519 antibody Targeting protein for Xklp2 antibody Differentially expressed in cancerous and non-cancerous lung cells 2 antibody DIL-2 antibody Hepatocellular carcinoma-associated antigen 519 antibody Protein fls353 antibody Restricted expression prolifera antibody